Mr. Ben van Kooten (1951), at present Business Group Director DSM Resins, will retire after a long and successful career at DSM of more than 35 years.

He will be succeeded by Mr. Dimitri de Vreeze (1967), at present Business Unit Director DSM NeoResins+. In this role he will report to Mr. Nico Gerardu, Member of the DSM Managing Board. Dimitri de Vreeze will work together with Ben van Kooten through a transition period and will assume responsibility for DSM Resins at the beginning of Q4 2010.

Mr. Steve Hartig (1958), at present President DSM Biomedical, will succeed Dimitri de Vreeze as Business Unit Director DSM NeoResins+. In this role he will report to Dimitri de Vreeze. As announced earlier, Steve Hartig will be succeeded as President DSM Biomedical by Mr. Christophe Dardel (1960) as per 15 May 2010.

DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic prosperity, environmental quality and social equity, which it pursues simultaneously and in parallel. DSM has annual net sales of about € 8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com